Type 2 Diabetes
The growing global geriatric population and the rising incidence and prevalence of T2 diabetes are significant factors expected to drive the growth of the diabetes drugs market, not only in mature markets but also in fast-growing countries. Capitalizing on our unique expertise in the diabetes market and in patient chart-based research, we have designed this study, with input from our clients, based on real-world data to monitor the evolution of T2 Diabetes management in some of the most dynamic markets.
Fill in the form below to access an overview of our T2 Diabetes syndicated study including:
- Types of data collected
- Dates of research waves